Anti –Neutrophil Extracellular Trap Antibodies and Impaired Neutrophil Extracellular Trap Degradation in Antiphospholipid Syndrome
ConclusionOur data indicate high levels of anti ‐NET antibodies in patients with primary APS, which may impair NET clearance and activate the complement cascade. These findings may ultimately enable more effective risk stratification.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Yu Zuo,
Srilakshmi Yalavarthi,
Kelsey Gockman,
Jacqueline A. Madison,
Johann E. Gudjonsson,
J. Michelle Kahlenberg,
W. Joseph McCune,
Paula L. Bockenstedt,
David R. Karp,
Jason S. Knight Tags: Brief Report Source Type: research
More News: Antiphospholipid Syndrome | Arthritis | Hughes Syndrome | Lupus | Rheumatology | Study | Thrombosis